Terms: = Kidney tumors AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Clinical Outcome
26 results:
1. Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Roller A; Davydov II; Schwalie PC; Serrano-Serrano ML; Heller A; Staedler N; Ferreira CS; Dietmann G; Klaman I; Valdeolivas A; Korski K; Cannarile MA
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38649280
[TBL] [Abstract] [Full Text] [Related]
2. Cigarette smoking and adverse health outcomes in patients treated with maintenance dialysis.
Bek SG; Marschner S; Sud K; Johnson DW; Chow CK; Hawley C; Pilmore H; Wong G; Lim W; Lee VW
Nephrology (Carlton); 2023 Jan; 28(1):21-27. PubMed ID: 36222366
[TBL] [Abstract] [Full Text] [Related]
3. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract] [Full Text] [Related]
4. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
5. Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer.
Vasileiadis T; Chrisofos M; Safioleas M; Kontzoglou K; Papazisis K; Sdrolia A
BMC Cancer; 2019 Apr; 19(1):407. PubMed ID: 31039771
[TBL] [Abstract] [Full Text] [Related]
6. Combined assessment of low PGRMC1/positive ATP1A1 levels has enhanced prognostic value for renal cell carcinoma.
He Y; Zhang P; Zhang D; Xia Z; Wang X; Deng S; Li H; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Sep; 40(3):1467-1476. PubMed ID: 30015972
[TBL] [Abstract] [Full Text] [Related]
7. Acquired Cystic Disease-associated Renal Cell Carcinoma (ACD-RCC): A Multiinstitutional Study of 40 Cases With clinical Follow-up.
Przybycin CG; Harper HL; Reynolds JP; Magi-Galluzzi C; Nguyen JK; Wu A; Sangoi AR; Liu PS; Umar S; Mehra R; Zhang X; Cox RM; McKenney JK
Am J Surg Pathol; 2018 Sep; 42(9):1156-1165. PubMed ID: 29851703
[TBL] [Abstract] [Full Text] [Related]
8. DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1.
Rosinha A; Assis J; Dias F; Nogueira A; Pereira D; Maurício J; Teixeira AL; Medeiros R
Med Oncol; 2015 Nov; 32(11):255. PubMed ID: 26493193
[TBL] [Abstract] [Full Text] [Related]
9. Percutaneous Cryoablation of clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term outcomes.
Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
[TBL] [Abstract] [Full Text] [Related]
10. MRI features of renal cell carcinoma that predict favorable clinicopathologic outcomes.
Doshi AM; Huang WC; Donin NM; Chandarana H
AJR Am J Roentgenol; 2015 Apr; 204(4):798-803. PubMed ID: 25794069
[TBL] [Abstract] [Full Text] [Related]
11. Bosniak classification system: inter-observer and intra-observer agreement among experienced uroradiologists.
Graumann O; Osther SS; Karstoft J; Hørlyck A; Osther PJ
Acta Radiol; 2015 Mar; 56(3):374-83. PubMed ID: 24682404
[TBL] [Abstract] [Full Text] [Related]
12. The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
de Martino M; Haitel A; Schatzl G; Klatte T
J Urol; 2013 Oct; 190(4):1392-7. PubMed ID: 23517743
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.
Teloken PE; Thompson RH; Tickoo SK; Cronin A; Savage C; Reuter VE; Russo P
J Urol; 2009 Nov; 182(5):2132-6. PubMed ID: 19758615
[TBL] [Abstract] [Full Text] [Related]
14. Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.
Vujanić GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
Pediatr Dev Pathol; 2009; 12(2):111-5. PubMed ID: 18811224
[TBL] [Abstract] [Full Text] [Related]
15. Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques?
Veltri A; Garetto I; Pagano E; Tosetti I; Sacchetto P; Fava C
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):76-85. PubMed ID: 18709413
[TBL] [Abstract] [Full Text] [Related]
16. Renal oncocytoma: clinical experience of Taipei Veterans General Hospital.
Fan YH; Chang YH; Huang WJ; Chung HJ; Chen KK
J Chin Med Assoc; 2008 May; 71(5):254-8. PubMed ID: 18490230
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome of long-term renal transplant survivors: a nephrourologic approach.
Awad MC; da Silva EA; Souza E; Damião R
Transplant Proc; 2008 Apr; 40(3):714-7. PubMed ID: 18454995
[TBL] [Abstract] [Full Text] [Related]
18. The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma.
Wu CF; Chang PL; Chen CS; Chuang CK; Weng HH; Pang ST
J Urol; 2006 Aug; 176(2):477-81. PubMed ID: 16813872
[TBL] [Abstract] [Full Text] [Related]
19. [Prognostic factors for brain metastatic tumors treated with stereotactic radiosurgery].
Xu BH; Han L; Lin SJ; Touboul E
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1425-8. PubMed ID: 16305972
[TBL] [Abstract] [Full Text] [Related]
20. CA9 expression as a prognostic factor in renal clear cell carcinoma.
Soyupak B; Erdoğan S; Ergin M; Seydaoğlu G; Kuzgunbay B; Tansuğ Z
Urol Int; 2005; 74(1):68-73. PubMed ID: 15711113
[TBL] [Abstract] [Full Text] [Related]
[Next]
